Moleculin Biotech, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-745.0K | $0 |
| FY2016 | — | $15.0M | $5.0M |
| FY2017 | — | $17.1M | $7.7M |
| FY2018 | — | $14.3M | $7.1M |
| FY2019 | — | $15.6M | $10.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-745.0K | $0 |
| FY2016 | — | $15.0M | $5.0M |
| FY2017 | — | $17.1M | $7.7M |
| FY2018 | — | $14.3M | $7.1M |
| FY2019 | — | $15.6M | $10.7M |